[Peripheral vasodilators in the treatment of heart failure].
D002302:Cardiac Output / Q000187:drug effects; D009202:Cardiomyopathies / Q000188:drug therapy; D003326:Coronary Circulation / Q000187:drug effects; D004329:Droperidol / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D009566:Nitrates / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000188:drug therapy; D013318:Stroke Volume / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D009566:Nitrates; D010879:Piperazines; D011799:Quinazolines; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; C005185:trimazosin; D007548:Isosorbide Dinitrate; D004329:Droperidol; D011224:Prazosin; D010646:Phentolamine
Perifericheskie vazodilatory pri lechenii serdechnoĭ nedostatochnosti.